Adipose Tissue Browning Mechanisms and Obesity Management

Adipose tissue browning has emerged as a promising strategy to enhance energy expenditure and counteract the global rise in obesity. In mammals, two principal fat types coexist: energy-storing white adipose tissue (WAT) and energy-dissipating brown adipose tissue (BAT). Under appropriate stimuli—such as cold exposure, certain hormones and nutritional factors—clusters of white adipocytes can adopt a brown-like or “beige” phenotype, characterised by high mitochondrial content and expression of uncoupling protein 1 (UCP1). This process of browning augments non-shivering thermogenesis and improves systemic metabolic health through enhanced lipid oxidation and glucose clearance. Mechanistically, browning is orchestrated by a network of transcriptional regulators and signalling pathways, including PGC-1α, PRDM16, β-adrenergic receptors and natriuretic peptides, as well as local factors such as fibroblast growth factor 21 (FGF21). Nutraceuticals and synthetic ligands that engage these pathways are under active investigation alongside lifestyle interventions. While preclinical models have demonstrated sustained weight reduction and insulin sensitivity gains, translation into safe, effective therapies in humans still faces challenges related to dosing, tissue targeting and long-term safety. Integrating molecular insights with advanced imaging and metabolic phenotyping will be crucial for harnessing browning as a viable component of obesity management worldwide.

Research from Nature Portfolio

Recent studies have delineated how lipid-sensing receptors and dietary fats can directly activate thermogenic programmes. One seminal investigation revealed that GPR120, a receptor for long-chain polyunsaturated fatty acids, is upregulated in active brown and beige adipocytes; its activation stimulates UCP1 expression and boosts secretion of FGF21, which in turn amplifies thermogenic capacity. In genetic models lacking GPR120 or FGF21, cold-induced browning and energy expenditure were markedly impaired, underscoring a lipid-receptor-growth factor axis. Complementary work has shown that dietary fish oil elevates sympathetic outflow to both classical BAT and beige depots via transient receptor potential vanilloid 1 (TRPV1) channels. This intervention enhanced noradrenaline turnover, β-adrenergic receptor signalling and UCP1 levels, leading to higher oxygen consumption and reduced adiposity in murine models.

Adipose Tissue Browning Mechanisms and Obesity Management publication trend

The graph below shows the total number of articles in adipose tissue browning mechanisms and obesity management across all publications each year (not limited to Nature Index journals).

Technical terms

Brown adipose tissue (BAT): specialised fat that dissipates energy as heat through non-shivering thermogenesis.
White adipose tissue (WAT): primary energy reservoir, storing excess calories as triglycerides.
Browning: transition of white adipocytes to a beige phenotype endowed with thermogenic machinery.
Uncoupling protein 1 (UCP1): mitochondrial inner-membrane protein that uncouples respiration to generate heat.
Beige adipocytes: inducible thermogenic cells arising within white fat depots under specific stimuli.
Fibroblast growth factor 21 (FGF21): endocrine factor that amplifies brown fat activation and systemic energy expenditure.

References

1. Is Propolis a Potential Anti-Obesogenic Agent for Obesity?. Current Nutrition Reports (2024).
2. Unraveling Obesity: Transgenerational Inheritance, Treatment Side Effects, Flavonoids, Mechanisms, Microbiota, Redox Balance, and Bioavailability—A Narrative Review. Antioxidants (2023).
3. Browning of Adipocytes: A Potential Therapeutic Approach to Obesity. Nutrients (2023).
4. The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes. Nature Communications (2016).
5. Fish oil intake induces UCP1 upregulation in brown and white adipose tissue via the sympathetic nervous system. Scientific Reports (2015).